Australia markets close in 2 hours 26 minutes

ClearPoint Neuro, Inc. (CLPT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.91+0.51 (+5.43%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close9.40
Open9.41
Bid9.29 x 2900
Ask10.50 x 800
Day's range9.34 - 10.07
52-week range7.00 - 16.96
Volume64,141
Avg. volume77,588
Market cap243.336M
Beta (5Y monthly)1.09
PE ratio (TTM)N/A
EPS (TTM)-0.72
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.00
  • GlobeNewswire

    ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue

    SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced preliminary, unaudited financial results for its fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Preliminary Unaudited Financial Highlights Preliminary unaudited revenue of $5.2 million, a 21% year-over-year increase;Increased biologics and drug delivery r

  • GlobeNewswire

    ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

    The ClearPoint Prism™ Neuro Laser Therapy System The ClearPoint Prism™ Neuro Laser Therapy System SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the first patient in a Glioblastoma clinical trial using the ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Lund, Sweden (SUS Lund). The Saf

  • GlobeNewswire

    ClearPoint Neuro to Present at Upcoming Investor Conferences

    SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the following investor conferences: 2022 Stifel Healthcare ConferencePresenting on Tuesday, November 15, 2022 at 10:55 a.m. Eastern Time in New York, NY. 34th Annual Piper Sandler Healthcare ConferencePresenting on Tuesday, November 29, 2022 at 1